Chemplast Sanmar
Chemplast Sanmar Q1 FY27 earnings call: Revenue & Margins
Q1 FY27 earnings call: what management said on revenue, margins and capex.
Guidance rank: #54 of 68 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q1 FY27 call signalled
2 of 4 strong
The short version
Specialty Chemicals segment shows strong growth with 21% YoY volume increase in Q1 FY27; expected to continue ramping up with 14 commercial molecules and ~50 in development across agchem, pharma, and specialty sectors. Specialty Chemicals segment shows healthy 21% YoY volume growth with a strong order book, expected to drive profitable growth.
From Chemplast Sanmar's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.
Revenue & Sales Performance
- Specialty Chemicals segment shows strong growth with 21% YoY volume increase in Q1 FY27; expected to continue ramping up with 14 commercial molecules and ~50 in development across agchem, pharma, and specialty sectors.
- Custom Manufacturing (CMCD) business has a strong order book and is on track to achieve INR1,000 crores revenue target; ramp-up of new capacities progressing with full utilization expected by FY27 end.
- Suspension PVC segment facing short-term challenges but expected to improve from Q3 FY27 onwards due to better PVC/VCM spreads supported by protective duties and market recovery.
2 more points from Chemplast Sanmar's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Chemplast Sanmar said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- Chemplast Sanmar is investing in capacity expansion in the specialty chemicals segment to drive profitable growth.
- The Custom Manufacturing Chemicals Division (CMCD) capacity has expanded significantly, for example from roughly 1,100 tons to 5,400 tons.
- Resources have been invested in Europe and Japan to support business development and possibly diversify beyond agrochemicals into pharmaceuticals and specialty chemicals.
- The company is on track to commission 14,000 tons of refrigerant gas (R32) capacity by the end of the current fiscal year.
2 more points from Chemplast Sanmar's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Chemplast Sanmar said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Custom Manufacturing business has a good order book with strong outlook and performance in Q1.
- The CMCD (Custom Manufacturing & Development) segment has a healthy order book supporting 60-70% utilization of commissioned assets.
- Currently, 14 molecules are in commercial production with around 50 molecules in various development stages in the pipeline.
- Strong order backlog exists for the remaining 9 months of the year.
- The business anticipates continued ramp-up and commercialization of additional molecules in the coming quarters.
- Active efforts are underway to diversify beyond agchem to pharma and specialty chemicals with projects in progress.
2 more points from Chemplast Sanmar's call on order book
Create a free account to keep reading this call
Chemplast Sanmar — Quarterly revenue & net profit
Q1 FY27 figures are not in this chart yet. Latest shown: Mar 2026 (Q4 FY26). The Q1 FY27 numbers from the filing are in the analysis on this page.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹1.3K Cr, net loss ₹45 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Chemplast Sanmar's management said in earlier quarters
- Q1 FY26 earnings call analysis →
- Q2 FY26 earnings call analysis →
- Q3 FY26 earnings call analysis →
- Q4 FY26 earnings call analysis →
- Q4 FY25 earnings call →
- Q3 FY25 earnings call →
- Q2 FY25 earnings call →
- Q1 FY25 earnings call →
- Q4 FY24 earnings call →
- Q3 FY24 earnings call →
- Q2 FY24 earnings call →
- Q1 FY24 earnings call →
Others in Chemicals & Petrochemicals this season
- Alufluoride (Q1 FY27)
Revenue from operations for Q1 FY27 was ₹26.6 crore, down 39% YoY (Page 6, 7, 8). Key investor presentation takeaways from Alufluoride Ltd's Q1 FY27 investor pr
- POCL Enterprises (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
- Devson Catalyst (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee
- Ambani Orgochem (Q1 FY27)
Financial highlights show Total Income in ₹ Lakhs: . Key investor presentation takeaways from Ambani Orgochem's Q1 FY27 investor presentation — and how it ranks
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Chemplast Sanmar and 15K+ more earnings calls,
for less than your morning chai
a day
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Chemplast Sanmar Q1 FY27 results?
Specialty Chemicals segment shows strong growth with 21% YoY volume increase in Q1 FY27; expected to continue ramping up with 14 commercial molecules and ~50 in development across agchem, pharma, and specialty sectors. Specialty Chemicals segment shows healthy 21% YoY volume growth with a strong order book, expected to drive profitable growth.
What is Chemplast Sanmar share price analysis?
Chemplast Sanmar currently shows a below-average growth signal. The stock trades at a P/E of N/A with a market cap of ₹2,797 Cr. Investors should review the full earnings analysis for detailed insights.
Is Chemplast Sanmar planning capital expenditure?
Chemplast Sanmar is investing in capacity expansion in the specialty chemicals segment to drive profitable growth.
Keep Chemplast Sanmar on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.